Search

Your search keyword '"Bian, Dongliang"' showing total 121 results

Search Constraints

Start Over You searched for: Author "Bian, Dongliang" Remove constraint Author: "Bian, Dongliang"
121 results on '"Bian, Dongliang"'

Search Results

2. Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II–III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study

8. Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II–III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial

10. Comparative Experimental Study on the De-Icing Performance of Multiple Actuators.

21. Additional file 2 of Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing

22. Additional file 1 of Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II–III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial

23. Additional file 4 of Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II–III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial

25. Efficacy evaluation of surgery combined with chemotherapy for stage IIIA small cell lung cancer patients: a retrospective analysis

29. Single-Cell RNA Sequencing Reveals Tumor Microenvironment Remodeling after Neoadjuvant Immunotherapy in Non-small Cell Lung Cancer

30. Effects of material degradation on electrical and optical characteristics of surface dielectric barrier discharge.

36. Study of Support Vector Regression for the in-process optical measurement of surface roughness using laser scattered images

41. 18F-FDG PET/CT in lung adenosquamous carcinoma and its correlation with clinicopathological features and prognosis.

47. Experimental investigation of a spanwise plasma jet array in a turbulent boundary layer for skin-friction drag reduction.

48. Inhibition of Bcl-2 and Bcl-xL overcomes the resistance to the third-generation EGFR tyrosine kinase inhibitor osimertinib in non-small cell lung cancer.

49. Vision system for surface roughness and surface defect measurement.

50. Does the number of cycles of neoadjuvant therapy affect the efficacy of neoadjuvant chemoimmunotherapy for non‐small cell lung cancer in locally advanced stage? Retrospective experience based on a single center.

Catalog

Books, media, physical & digital resources